These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9188867)

  • 1. Immunoblot analysis of autoantigens in localized pemphigoid and pemphigoid nodularis.
    Kawahara Y; Matsumura K; Hashimoto T; Nishikawa T
    Acta Derm Venereol; 1997 May; 77(3):187-90. PubMed ID: 9188867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid sera that contain antibodies to BPAg2 also contain antibodies to LABD97 that recognize epitopes distal to the NC16A domain.
    Egan CA; Taylor TB; Meyer LJ; Petersen MJ; Zone JJ
    J Invest Dermatol; 1999 Feb; 112(2):148-52. PubMed ID: 9989788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
    Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
    J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin.
    Sitaru C; Schmidt E; Petermann S; Munteanu LS; Bröcker EB; Zillikens D
    J Invest Dermatol; 2002 Apr; 118(4):664-71. PubMed ID: 11918714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies from patients with localized and generalized bullous pemphigoid immunoprecipitate the same 230-kd keratinocyte antigen.
    Domloge-Hultsch N; Utecht L; James W; Yancey KB
    Arch Dermatol; 1990 Oct; 126(10):1337-41. PubMed ID: 2221940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized pretibial pemphigoid and pemphigoid nodularis.
    Borradori L; Prost C; Wolkenstein P; Bernard P; Baccard M; Morel P
    J Am Acad Dermatol; 1992 Nov; 27(5 Pt 2):863-7. PubMed ID: 1469147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine bullous pemphigoid (BP): identification of the 180-kd canine BP antigen by circulating autoantibodies.
    Iwasaki T; Olivry T; Lapiere JC; Chan LS; Peavey C; Liu YY; Jones JC; Ihrke PJ; Woodley DT
    Vet Pathol; 1995 Jul; 32(4):387-93. PubMed ID: 7483213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen.
    Murakami H; Amagai M; Higashiyama M; Hashimoto K; Chorzelski TP; Bhogal BS; Jenkins RE; Black MM; Zillikens D; Nishikawa T; Hashimoto T
    J Dermatol Sci; 1996 Nov; 13(2):112-7. PubMed ID: 8953410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigoid nodularis: a case with 230 kDa hemidesmosomes antigen associated with bullous pemphigoid antigen.
    Tamada Y; Yokochi K; Oshitani Y; Nitta Y; Ikeya T; Hara K; Owaribe K
    J Dermatol; 1995 Mar; 22(3):201-4. PubMed ID: 7738277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen.
    Matsumura K; Amagai M; Nishikawa T; Hashimoto T
    Arch Dermatol Res; 1996 Aug; 288(9):507-9. PubMed ID: 8874743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
    Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
    J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to bullous pemphigoid antigen 1 binds to the antigen at perilesional but not uninvolved skin, in localized bullous pemphigoid.
    Seishima M; Izumi T; Kitajima Y
    Eur J Dermatol; 1999; 9(1):39-42. PubMed ID: 9920986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot analysis using recombinant protein of the 180 kD bullous pemphigoid antigen NC16a domain as an aid to the diagnosis of atypical subepidermal autoimmune bullous skin diseases.
    Hashimoto T; Matsumura K; Kawahara Y; Ohata Y; Nishikawa T
    Keio J Med; 1995 Jun; 44(2):62-6. PubMed ID: 7658646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule.
    Hamada T; Nagata Y; Tomita M; Salmhofer W; Hashimoto T
    Exp Dermatol; 2001 Aug; 10(4):256-63. PubMed ID: 11493314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of bullous pemphigoid antibodies by use of recombinant bullous pemphigoid antigen proteins.
    Tanaka M; Hashimoto T; Amagai M; Shimizu N; Ikeguchi N; Tsubata T; Hasegawa A; Miki K; Nishikawa T
    J Invest Dermatol; 1991 Oct; 97(4):725-8. PubMed ID: 1940445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.